Zobrazeno 1 - 10
of 31
pro vyhledávání: '"O. Nantes Castillejo"'
Autor:
M. Vicuña Arregui, D. Ruiz-Clavijo García, J. M. Zozaya Urmeneta, F. Bolado Concejo, O. Nantes Castillejo
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 102, Iss 4, Pp 287-287 (2010)
Externí odkaz:
https://doaj.org/article/14e9560cfe6340a7902b9ae8bd69be74
Autor:
M Chaparro, M García Donday, S Riestra, A J Lucendo, J M Benítez, M Navarro-Llavat, J Barrio, V J Morales-Alvarado, M Rivero, D Busquets, E Leo Carnerero, O Merino Ochoa, O Nantes Castillejo, P Navarro, M Van Domselaar, A Gutiérrez Casbas, I Alonso-Abreu, R Mejuto, L Fernández Salazar, M Iborra, M D Martín-Arranz, J R Pineda, M J Sampedro, K Serra Nilsson, A Bouhmidi Assakali, L Batista, C Muñoz Villafranca, I Rodríguez-Lago, D S Ceballos Santos, I Guerra, M Mañosa, I Marín Jimenez, I Vera Mendoza, M Barreiro-de Acosta, E Domènech, M Esteve, V García-Sánchez, P Nos, J Panés, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i50-i54
Background Background: The feasibility of anti-TNF discontinuation in inflammatory bowel disease (IBD) must be proven in clinical trials including patients in clinical, endoscopic, and radiologic remission at the time of anti-TNF withdrawal to make r
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C Rodríguez Gutiérrez, S Rubio Iturria, A Elosua Gonzalez, M Rullan Iriarte, JF Juanmartiñena Fernández, M. Vicuña Arregui, I Elizalde Apesteguía, I. Fernández-Urién, M R Aznárez Barrio, O. Nantes Castillejo
Publikováno v:
Journal of Crohn's and Colitis. 15:S417-S418
Background An important factor that limits a wider utilization of small bowel capsule endoscopy (SBCE) in Crohn’s Disease (CD) is the potential risk of retention. The Patency® capsule (PC) lowers the risk of SBCE retention by assessing pre-procedu
Autor:
E Macías Mendizábal, S Oquiñena Legaz, M Rullan Iriarte, C Rodríguez Gutiérrez, O. Nantes Castillejo, I. Fernandez-Urien Sainz, A. Borda Martín, S Rubio Iturria, A Elosua Gonzalez
Publikováno v:
Journal of Crohn's and Colitis. 15:S423-S424
Background Capsule endoscopy (SBCE) has developed a relevant role in different indications in patients with established Crohn’s Disease (CD). However, evaluation of its impact in clinical management in CD specific modification strategies has been s
Publikováno v:
Revista de Gastroenterología de México. 83:463-465
Publikováno v:
Revista de Gastroenterología de México (English Edition). 83:463-465
Autor:
M A Vicuña, C Rodríguez Gutiérrez, A Elosua Gonzalez, S Rubio Iturria, C. Prieto Martínez, O. Nantes Castillejo
Publikováno v:
Journal of Crohn's and Colitis. 14:S295-S296
Background Knowing the natural history of ulcerative colitis (UC) is essential to understand the evolution of the disease, assess the impact of different therapeutic strategies, identify poor prognostic factors and provide patients with understandabl
Autor:
O. Nantes Castillejo, J. A. Olmos-Jérez, E De La Santa Belda, L. Ruiz-Rebollo, J. Barrio-Andrés, B. López Viedma, B. Madrigal Rubiales, E. Valdivieso-Cortazar, N. Alcaide-Suarez, A. Boumidi, E. Gonzalez-Obeso, Isabel Pérez-Martínez, G. Payeras-Llodra, J. Rodríguez-Sánchez, Javier Molina-Infante
Publikováno v:
Alimentary Pharmacology & Therapeutics. 45:300-309
SummaryBackground Conflicting results have been recently reported for the accuracy of the Endoscopic Reference Score (EREFS), an standardised endoscopic classification, to predict the histological activity of eosinophilic oesophagitis (EoE). Aim To e
Publikováno v:
Enfermedad Inflamatoria Intestinal al Día. 15:72-75
Resumen Dentro de los farmacos habitualmente utilizados para el manejo de la enfermedad inflamatoria intestinal se encuentran los 5-ASA y entre ellos la mesalazina. A pesar de tener buen perfil de tolerancia y escasas reacciones adversas, que habitua